Approved Products > Gardasil

Gardasil

Proper Name: Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant
Tradename: Gardasil
Manufacturer: Merck & Co., Inc, License #0002
Indications:

* Prevention of vulvar and vaginal cancer
* Vaccination in females 9 to 26 years of age for prevention of the following diseases caused by Human Papillomavirus (HPV) Types 6, 11, 16, and 18:
o Cervical cancer
o Genital warts (condyloma acuminata) and the following precancerous or dysplastic lesions:
+ Cervical adenocarcinoma in situ (AIS)
+ Cervical intraepithelial neoplasia (CIN) grade 2 and grade 3
+ Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3
+ Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3
+ Cervical intraepithelial neoplasia (CIN) grade 1
* Vaccination in boys and men 9 through 26 years of age for the prevention of genital warts caused by HPV types 6 and 11
* Vaccination in people ages 9 through 26 years for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18

Approved Products > Gardasil